STERIS plc
STELast close · Oct 16, 2026222.66−1.67 (−0.74%)
Market cap$21.7B
3 firms' latest targets, last 12 months: median $270.00 ($269.00–$275.00), 21% above the last close.
Price and published targets
Each firm's latest target
| Date | Firm | Target | Change | Vs price now |
|---|---|---|---|---|
| 2026-07-28 | UBS | $275.00 | — | +24% |
| 2026-05-21 | Piper Sandler | $270.00 | — | +21% |
| 2026-05-13 | KeyBanc | $269.00 | — | +21% |
Consensus estimates
| FY | Revenue | YoY | EPS | YoY | Revenue range | EPS range | Analysts |
|---|---|---|---|---|---|---|---|
| 2022reported | $4.6B | +48% | $2.48 | -46% | est. $4.5B+1% | est. $7.90 | 1 |
| 2023reported | $5.0B | +8% | $1.07 | -57% | est. $4.8B+2% | est. $8.05 | 2 |
| 2024reported | $5.1B | +4% | $3.81 | +256% | est. $5.4B-6% | est. $8.60 | 5 |
| 2025reported | $5.5B | +6% | $6.20 | +63% | est. $5.4B+0% | est. $9.10 | 6 |
| 2026reported | $5.9B | +9% | $7.93 | +28% | est. $5.9B+0% | est. $10.20 | 6 |
| 2027 | $6.4B | +7% | $11.21 | +10% | $6.4B–$6.4B | $10.98–$11.34 | 5 |
| 2028 | $6.8B | +6% | $12.25 | +9% | $6.7B–$6.8B | $12.23–$12.28 | 5 |
| 2029 | $7.2B | +6% | $13.47 | +10% | $7.2B–$7.3B | $12.41–$15.33 | 3 |
Targets, grades and estimates are quoted from third parties (via Financial Modeling Prep) and are theirs, not ours; each target links to the report it was published in. A firm counts once, at its latest target or grade.